SCHEMBL7048807

SCHEMBL7048807

c1ccc(Oc2ccc(-c3ccn(-c4ccncc4)n3)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN4A P35499 4/20 0.51
TNK2 Q07912 3/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
LTA4H P09960 3/20 0.42
HRH2 P25021 1/20 0.40
HRH1 P35367 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 2/20 0.39
MEN1 O00255 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15072164 0.86 KMT2A (0.50) KMT2AKDM4EALDH1A1MEN1SMN1; SMN2
SCHEMBL2148390 0.82 ALDH1A1 (0.46) KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL27743341 0.78 GRM5 (0.52) SCN4ATNK2CA1CA2NPC1
SCHEMBL12857463 0.77 ABCB11 (0.58) NPC1RAB9AKMT2AKDM4EALDH1A1
SCHEMBL27764186 0.77 FYN (0.50) SCN4ATNK2CA1CA2NPC1
SCHEMBL218118 0.75 KMT2A (0.57) NPC1RAB9AKMT2AKDM4EALDH1A1
SCHEMBL4316115 0.74 ABCB11 (0.55) NPC1RAB9AKMT2AKDM4EALDH1A1
Ammonia Solution, Strong SCHEMBL10418488 0.73 KMT2A (0.55) NPC1RAB9AKMT2AKDM4EALDH1A1
SCHEMBL27568071 0.73 SCN4A (0.61) SCN4ACA1CA2NPC1RAB9A
SCHEMBL7011494 0.73 NOTUM (0.61) SCN4ATNK2NPC1RAB9ALTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101426792-A Pyrazolopyrimidines as therapeutic agents ABBOTT GMBH & CO KG (DE) 2009-05-06 CN disclosed
WO-2004100868-A2 METHOD OF TREATING TRANSPLANT REJECTION ABBOTT LABORATORIES (US) 2004-11-25 WO disclosed